PRACA POGLĄDOWA
Amblyopia in the pediatric population – etiopathogenesis and current therapeutic approaches. A review of recent literature
1
2nd Department of Ophthalmology – Pediatric Ophthalmology Ward, University Hospital No. 2 in Szczecin, Poland
Data publikacji: 22-10-2026
Ophthalmology 2026;29(3):13-19
SŁOWA KLUCZOWE
STRESZCZENIE
Amblyopia is a visual development disorder defined as a reduction in best-corrected visual acuity. It is the most common cause of unilateral visual impairment in the pediatric population, affecting approximately 1% to 5% of children worldwide. According to current literature, the global burden of amblyopia may reach 221.9 million people by 2040.
The most common causes of amblyopia include strabismus (19%–50%), refractive errors (46%–79%), anisometropia, and optical media opacities.
Therapeutic management involves stepwise refractive correction, occlusion of the better-seeing eye, or atropine penalization, complemented by selected optical or surgical approaches in deprivation-related cases. In recent years, binocular (dichoptic) therapies, such as digital platforms and eye-tracking systems aimed at reducing suppression and improving binocular function, have gained increasing attention. Early detection, individualized treatment plans, and systematic monitoring remain essential for achieving sustained visual improvement. This article reviews the 2020–2026 literature on the etiopathogenesis, diagnosis, and current management strategies for amblyopia in children.
REFERENCJE (47)
1.
Hernández-Rodríguez CJ, Piñero DP: Active Vision Therapy for Anisometropic Amblyopia in Children: A Systematic Review. J Ophthalmol. 2020; 2020(1): 4282316. doi:10.1155/2020/4282316.
2.
Fu Z, Hong H, Su Z, et al.: Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. Br J Ophthalmol. 2020; 104(8): 1164–1170. doi:10.1136/bjophthalmol-2019-314759.
3.
Hu B, Liu Z, Zhao J, et al.: The Global Prevalence of Amblyopia in Children: A Systematic Review and Meta-Analysis. Front Pediatr. 2022; 10. doi:10.3389/fped.2022.819998.
4.
Papageorgiou E, Asproudis I, Maconachie G, et al.: The treatment of amblyopia: current practice and emerging trends. Graefes Arch Clin Exp Ophthalmol. 2019; 257(6): 1061–1078. doi:10.1007/s00417-019-04254-w.
5.
Morse J, Oatts JT: Amblyopia screening: the current state and opportunities for optimization. Expert Rev Med Devices. 2025; 22(1): 1–4. doi:10.1080/17434440.2024.2449490.
6.
Polskie Towarzystwo Okulistyczne; Polskie Towarzystwo Pediatryczne. Stanowisko ekspertów w sprawie przesiewowych badań wzroku u dzieci. 2020. https://pto.com.pl/wp-content/.... Accessed February 22, 2026.
7.
Meier K, Tarczy-Hornoch K: Recent Treatment Advances in Amblyopia. Annu Rev Vis Sci. 2022; 8(Vol. 8, 2022): 323–343. doi:10.1146/annurev-vision-100720-022550.
8.
Kaur S, Sharda S, Aggarwal H, et al.: Comprehensive review of amblyopia: Types and management. Indian J Ophthalmol. 2023; 71(7): 2677. doi:10.4103/IJO.IJO_338_23.
9.
Younan MH, Youssef YT, Erum U, et al.: Evolving Strategies in Amblyopia Management: From Traditional Therapies to Cutting-Edge Innovations. Cureus. Published online July 15, 2025. doi:10.7759/cureus.88012.
10.
Birch EE, Kelly KR, Wang J: Recent Advances in Screening and Treatment for Amblyopia. Ophthalmol Ther. 2021; 10(4): 815–830. doi:10.1007/s40123-021-00394-7.
11.
Alrasheed SH, Aldakhil S: Childhood amblyopia: A systematic review of recent management options. Saudi J Ophthalmol. 2024; 38(3): 201–213. doi:10.4103/sjopt.sjopt_212_23.
12.
Wright KW, Spiegel PH, Thompson L: Handbook of Pediatric Strabismus and Amblyopia. Am Orthopt J. 2006; 56(1): 200–201. doi:10.3368/aoj.56.1.200-a.
13.
Repka MX: Amblyopia Outcomes Through Clinical Trials and Practice Measurement: Room for Improvement: The LXXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2020; 219: A1-A26. doi:10.1016/j.ajo.2020.07.053.
14.
Chia A, Lin X, Dirani M, et al.: Risk Factors for Strabismus and Amblyopia in Young Singapore Chinese Children. Ophthalmic Epidemiol. 2013; 20(3): 138–147. doi:10.3109/09286586.2013.767354.
15.
Xiao O, Morgan IG, Ellwein LB, et al.: Prevalence of Amblyopia in School-Aged Children and Variations by Age, Gender, and Ethnicity in a Multi-Country Refractive Error Study. Ophthalmology. 2015; 122(9): 1924– –1931. doi:10.1016/j.ophtha.2015.05.034.
16.
Pediatric Eye Disease Investigator Group. A Randomized Trial of Atropine vs Patching for Treatment of Moderate Amblyopia in Children. Arch Ophthalmol. 2002; 120(3): 268. doi:10.1001/archopht.120.3.268.
17.
Pediatric Eye Disease Investigator Group. A Randomized Trial of Patching Regimens for Treatment of Moderate Amblyopia in Children. Arch Ophthalmol. 2003; 121(5): 603. doi:10.1001/archopht.121.5.603.
18.
Cruz OA, Repka MX, Hercinovic A, et al.: Amblyopia Preferred Practice Pattern. Ophthalmology. 2023; 130(3): P136–P178. doi:10.1016/j.ophtha.2022.11.003.
19.
Department of the air force. Air force instruction 48–123: Medical examinations and standards. 5 november 2013; including supplement 23 october 2014. https://www.e-publishing.af.mi....
20.
Alaska Blind Child Discovery. Screening Validation / MEPEDS criteria. ABCD-Vision.org. https://www.abcd-vision.org/is.... Accessed February 22, 2026.
21.
Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. American Association of Certified Orthoptists, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Eye examination in infants, children, and young adults by pediatricians. Pediatrics. 2003; 111(4 Pt 1): 902–907.
22.
American Academy of Ophthalmology. Vision Screening for Infants and Children. American Academy of Ophthalmology Clinical Statement. Published October 2022. https://www.aao.org/education/.... Accessed February 22, 2026.
23.
Cotter SA: Treatment of Anisometropic Amblyopia in Children with Refractive Correction. Ophthalmology. 2006; 113(6): 895–903. doi: 10.1016/j.ophtha.2006.01.068.
24.
Wallace DK: A Randomized Trial to Evaluate 2 Hours of Daily Patching for Strabismic and Anisometropic Amblyopia in Children. Ophthalmology. 2006; 113(6): 904–912. doi:10.1016/j.ophtha.2006.01.069.
25.
Kvarnström G, Jakobsson P, Lennerstrand G: Visual screening of Swedish children: An ophthalmological evaluation. Acta Ophthalmol Scand. 2001; 79(3): 240–244. doi:10.1034/j.1600-0420.2001.790306.x.
26.
Kim SJ, Jeon H, Jung JH, et al.: Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2018; 256(2): 429–437. doi:10.1007/s00417-017-3851-2.
27.
Holmes JM, Kraker RT, Beck RW, et al.: A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003; 110(11): 2075–2087. doi:10.1016/j.ophtha.2003.08.001.
28.
Holmes JM, Beck RW, Kraker RT, et al.: Impact of Patching and Atropine Treatment on the Child and Family in the Amblyopia Treatment Study. Arch Ophthalmol. 2003; 121(11): 1625. doi:10.1001/archopht.121.11.1625.
29.
Wang S, Wen W, Zhu W, et al.: Effect of Combined Atropine and Patching vs Patching Alone for Treatment of Severe Amblyopia in Children Aged 3 to 12 Years. JAMA Ophthalmol. 2021; 139(9): 990–996. doi:10.1001/jamaophthalmol.2021.2413.
30.
France TD, France LW: Optical penalization can improve vision after occlusion treatment. J Am Assoc Pediatr Ophthalmol Strabismus. 1999; 3(6): 341–343. doi:10.1016/S1091-8531(99)70042-X.
31.
Carvalho Soares Valentim C, Melchior Maia Lopes G, Chavez MP, et al.: Effectiveness of Video-Based Dichoptic Therapy vs. Patching in Children with Amblyopia. Ophthalmology. Published online October 2025: S0161642025006803. doi:10.1016/j.ophtha.2025.10.013.
32.
American Academy of Ophthalmology. Understanding Digital Treatments for Amblyopia. Young Ophthalmologists Info. https://www.aao.org/young-opht.... Accessed February 22, 2026.
33.
Xiao S, Angjeli E, Wu HC, et al.: Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia. Ophthalmology. 2022; 129(1): 77–85. doi:10.1016/j.ophtha.2021.09.001.
34.
Zhu W, Gu S, Li J, et al.: Transformative Gamified Binocular Therapy for Unilateral Amblyopia in Young Children: Pilot Prospective Efficacy and Safety Study. JMIR Serious Games. 2025; 13: e63384-e63384. doi:10.2196/63384.
35.
Wygnanski-Jaffe T, Kushner BJ, Moshkovitz A, et al.: An Eye-Tracking–Based Dichoptic Home Treatment for Amblyopia. Ophthalmology. 2023; 130(3): 274–285. doi:10.1016/j.ophtha.2022.10.020.
36.
Wygnanski-Jaffe T, Moshkovitz A, Kushner BJ, et al.: Binocular Home Treatment for Amblyopia: Gains Stable for One Year. Am J Ophthalmol. 2024; 262: 199–205. doi:10.1016/j.ajo.2024.02.004.
37.
Yabanoğlu D, Taylan Şekeroğlu H: Binocular Approaches in Amblyopia Treatment Based on Dichoptic Stimulation. Turk J Ophthalmol. Published online May 21, 2025. doi:10.4274/tjo.galenos.2025.06626.
38.
Basoglu Y, Serbetcioglu MB, Cicek FD: AmblyoPlay-based multimodal visual therapy in pediatric anisometropic amblyopia: a pilot study of visual, oculomotor and sensorimotor outcomes. BMC Ophthalmol. 2025; 25(1): 648. doi:10.1186/s12886-025-04481-2.
39.
Amblyopia Emerging Treatments. American Academy of Ophthalmology. October 21, 2015. Accessed February 11, 2026. https://www.aao.org/education/....
40.
Repka MX, Kraker RT, Dean TW, et al.: A Randomized Trial of Levodopa as Treatment for Residual Amblyopia in Older Children. Ophthalmology. 2015; 122(5): 874–881. doi:10.1016/j.ophtha.2015.01.002.
41.
Pawar PV, Mumbare SS, Patil MS, et al.: Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: A randomized controlled trial. Indian J Ophthalmol. 2014; 62(2): 124–129. doi:10.4103/0301-4738.128586.
42.
Huttunen HJ, Palva JM, Lindberg L, et al.: Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. Sci Rep. 2018; 8(1): 12830. doi:10.1038/s41598-018-31169-z.
43.
Wu C, Gaier ED, Nihalani BR, et al.: Recovery from amblyopia with cholinesterase inhibition. J Am Assoc Pediatr Ophthalmol Strabismus. 2022; 26(4): e60. doi:10.1016/j.jaapos.2022.08.225.
44.
Suttle CM: Active treatments for amblyopia: a review of the methods and evidence base. Clin Exp Optom. 2010; 93(5): 287–299. doi:10.1111/j.1444-0938.2010.00486.x.
45.
Scheiman M, Wick B: Clinical Management of Binocular Vision: Heterophoric, Accommodative, and Eye Movement Disorders. 4th ed. Philadelphia, PA: Wolters Kluwer; 2014.
46.
Holmes JM, Melia M, Bradfield YS, et al.: Factors Associated with Recurrence of Amblyopia on Cessation of Patching. Ophthalmology. 2007; 114(8): 1427–1432. doi:10.1016/j.ophtha.2006.11.023.
47.
Holmes JM: The Amblyopia Treatment Study Visual Acuity Testing Protocol. Arch Ophthalmol. 2001; 119(9): 1345. doi:10.1001/archopht.119.9.1345.
Udostępnij
ARTYKUŁ POWIĄZANY
| eISSN: | 1689-362X |
| ISSN: | 1505-2753 |
Przetwarzamy dane osobowe zbierane podczas odwiedzania serwisu. Realizacja funkcji pozyskiwania informacji o użytkownikach i ich zachowaniu odbywa się poprzez dobrowolnie wprowadzone w formularzach informacje oraz zapisywanie w urządzeniach końcowych plików cookies (tzw. ciasteczka). Dane, w tym pliki cookies, wykorzystywane są w celu realizacji usług, zapewnienia wygodnego korzystania ze strony oraz w celu monitorowania ruchu zgodnie z Polityką prywatności. Dane są także zbierane i przetwarzane przez narzędzie Google Analytics (więcej).
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
